Press Release: EsoCap : EsoCap - unique targeted application platform to treat the upper gastrointestinal tract
EsoCaps targeted application technology drastically increases mucosal contact time and enables effective local treatment of various esophageal diseases for the first...
Read full article »
EsoCap is a Switzerland-based biotechnology company that develops and commercializes novel therapies for the treatment of esophageal diseases.
Read more